- Home
- RPID vs CVRX Comparison
RPID vs CVRX Comparison
Compare RPID & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPID | CVRX |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.3M | 237.1M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RPID | CVRX |
|---|---|---|
| Price | $2.15 | $7.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $8.00 | ★ $11.20 |
| AVG Volume (30 Days) | ★ 281.4K | 195.0K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.78 | ★ 23.02 |
| EPS | ★ N/A | N/A |
| Revenue | $33,587,000.00 | ★ $56,651,000.00 |
| Revenue This Year | $19.12 | $16.65 |
| Revenue Next Year | $18.42 | $18.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 19.74 | 10.45 |
| 52 Week Low | $2.00 | $4.37 |
| 52 Week High | $4.94 | $11.30 |
Technical Indicators
Market Signals| Indicator | RPID | CVRX |
|---|---|---|
| Relative Strength Index (RSI) | 32.52 | 38.06 |
| Support Level | $2.01 | $6.71 |
| Resistance Level | $4.48 | $8.51 |
| Average True Range (ATR) | 0.20 | 0.72 |
| MACD | 0.03 | -0.25 |
| Stochastic Oscillator | 19.30 | 19.09 |
Price Performance
Historical ComparisonAbout RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.